Advancing Child Survival Through Vaccines and Innovation
- October 29, 2025
- 1 min read
Dr. Victoria Nankabirwa is leading groundbreaking research at MakSPH to improve immunisation and child survival. She recently led a clinical trial of nearly 6,000 children comparing the current BCG vaccine with a new TB vaccine candidate, VPM1002, offering hope for stronger protection. Her team also demonstrated that applying chlorhexidine to the umbilical cord can reduce severe newborn illness by 60%. Through vaccines, antiseptics, and innovative epidemiological methods, Dr. Nankabirwa’s work is shaping policies and advancing equitable access to life-saving interventions.
© Powered By Votre Technologies